rs2679757

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_148174.4(AZIN1):​c.-233-440T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.376 in 152,068 control chromosomes in the GnomAD database, including 11,696 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 11696 hom., cov: 32)

Consequence

AZIN1
NM_148174.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.205

Publications

8 publications found
Variant links:
Genes affected
AZIN1 (HGNC:16432): (antizyme inhibitor 1) The protein encoded by this gene belongs to the antizyme inhibitor family, which plays a role in cell growth and proliferation by maintaining polyamine homeostasis within the cell. Antizyme inhibitors are homologs of ornithine decarboxylase (ODC, the key enzyme in polyamine biosynthesis) that have lost the ability to decarboxylase ornithine; however, retain the ability to bind to antizymes. Antizymes negatively regulate intracellular polyamine levels by binding to ODC and targeting it for degradation, as well as by inhibiting polyamine uptake. Antizyme inhibitors function as positive regulators of polyamine levels by sequestering antizymes and neutralizing their effect. This gene encodes antizyme inhibitor 1, the first member of this gene family that is ubiquitously expressed, and is localized in the nucleus and cytoplasm. Overexpression of antizyme inhibitor 1 gene has been associated with increased proliferation, cellular transformation and tumorigenesis. Gene knockout studies showed that homozygous mutant mice lacking functional antizyme inhibitor 1 gene died at birth with abnormal liver morphology. RNA editing of this gene, predominantly in the liver tissue, has been linked to the progression of hepatocellular carcinoma. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.448 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AZIN1NM_148174.4 linkc.-233-440T>C intron_variant Intron 1 of 11 ENST00000337198.10 NP_680479.1 O14977A0A024R9C7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AZIN1ENST00000337198.10 linkc.-233-440T>C intron_variant Intron 1 of 11 1 NM_148174.4 ENSP00000337180.5 O14977
ENSG00000289653ENST00000695129.1 linkc.55-440T>C intron_variant Intron 1 of 1 ENSP00000511718.1 A0A8V8TII8

Frequencies

GnomAD3 genomes
AF:
0.376
AC:
57145
AN:
151950
Hom.:
11703
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.218
Gnomad AMI
AF:
0.555
Gnomad AMR
AF:
0.457
Gnomad ASJ
AF:
0.393
Gnomad EAS
AF:
0.235
Gnomad SAS
AF:
0.462
Gnomad FIN
AF:
0.508
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.435
Gnomad OTH
AF:
0.388
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.376
AC:
57153
AN:
152068
Hom.:
11696
Cov.:
32
AF XY:
0.381
AC XY:
28344
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.217
AC:
9018
AN:
41490
American (AMR)
AF:
0.457
AC:
6978
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.393
AC:
1362
AN:
3470
East Asian (EAS)
AF:
0.234
AC:
1214
AN:
5178
South Asian (SAS)
AF:
0.460
AC:
2218
AN:
4818
European-Finnish (FIN)
AF:
0.508
AC:
5363
AN:
10562
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.435
AC:
29573
AN:
67966
Other (OTH)
AF:
0.390
AC:
822
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1757
3513
5270
7026
8783
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.396
Hom.:
1661
Bravo
AF:
0.362
Asia WGS
AF:
0.390
AC:
1357
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.5
DANN
Benign
0.56
PhyloP100
0.20
PromoterAI
0.0061
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2679757; hg19: chr8-103870818; API